Maxwell Cretcher (@mcretcher) 's Twitter Profile
Maxwell Cretcher

@mcretcher

Vascular & Interventional Radiologist | BAMC IR | @dotter_IR | @OHSURadiology

ID: 1190864431825055749

calendar_today03-11-2019 05:33:10

17 Tweet

72 Followers

95 Following

Society of Thoracic Radiology (@thoracicrad) 's Twitter Profile Photo

56 year-old man with sudden onset chest pain & shortness of breath… presented by Drs. Maxwell Cretcher, Gurion Lantz, and Dr. Cristina Fuss from @OHSUsurgery & OHSU Radiology. thoracicrad.org/assets/index/2…

Society of Thoracic Radiology (@thoracicrad) 's Twitter Profile Photo

September 2020 Thoracic Case of the Month: Asymptomatic 15-year-old boy presented for evaluation of a thoracic finding on prior scoliosis radiograph. History of nevus lipomatosis… presented by Drs. Neel Patel & Katharine Hopkins from OHSU Radiology. thoracicrad.org/assets/index/2…

September 2020 Thoracic Case of the Month:

Asymptomatic 15-year-old boy presented for evaluation of a thoracic finding on prior scoliosis radiograph. History of nevus lipomatosis… presented by Drs. Neel Patel &amp; Katharine Hopkins from <a href="/OHSURadiology/">OHSU Radiology</a>.

thoracicrad.org/assets/index/2…
The Dotter Institute (@dotter_ir) 's Twitter Profile Photo

The Dotter Institute / Oregon Health and Science University is hosting a Virtual Meet and Greet Session for IR Residency applicants for this match season on October 8th at 5 pm PST. Register here: docs.google.com/forms/d/1K_434… #IRad

The Dotter Institute / Oregon Health and Science University is hosting a Virtual Meet and Greet Session for IR Residency applicants for this match season on October 8th at 5 pm PST. Register here: docs.google.com/forms/d/1K_434… #IRad
OHSU Radiology (@ohsuradiology) 's Twitter Profile Photo

Happy World #Theranostics Day! The field had a major advancement last week with the approval of Lu177-PSMA-617 (Pluvicto) for the treatment of metastatic castrate-resistant #ProstateCancer ! OHSU was instrumental in the study. news.ohsu.edu/2022/03/29/ohs…

Happy World #Theranostics Day! The field had a major advancement last week with the approval of Lu177-PSMA-617 (Pluvicto) for the treatment of metastatic castrate-resistant #ProstateCancer ! OHSU was instrumental in the study. news.ohsu.edu/2022/03/29/ohs…